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This bulletin presents key findings on polydrug use (the use of more than one substance within a specific time period). 
Analysis was carried out on the data collected for last month use which reflects current use. The focus is on the 
combinations of both legal and illegal drugs based on information obtained from the first drug prevalence survey  
of households to be carried out in both Ireland and Northern Ireland. The survey sampled a representative number  
of people aged between 15 and 64 during late 2002 and early 2003. The survey was undertaken by MORI MRC  
according to standards set by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
IRELAND – Key Findings
■ Nearly one-fifth of people in Ireland had 
not used any drugs (legal or illegal) in 
the last month.
■ The most commonly reported form of 
polydrug use involved alcohol and tobacco.
■ 5% of the respondents had used 
tobacco only in the previous month.
■ Polydrug use involving illegal substances 
is small at 1.93%.
■ A higher percentage of women 
(22%) than men (16%) reported not 
consuming any drug (legal or illegal) 
during the last month.
■ The combination of alcohol, tobacco 
and any illegal drug was much more 
common among males (2.65%) than 
females (1.20%).
■ More young adults aged 15-34 
combined alcohol, tobacco and any 
illegal drug (3.36%) than older adults 
aged 35-64 which was 0.64%.
■ Four-fifths (81.9%) of those who had 
smoked tobacco, had also used alcohol 
in the last month.
■ Of those who had used cannabis, over 
90% had also used alcohol and 84% 
had smoked tobacco in the last month.
■ Users of cannabis, amphetamine-type 
stimulants, and cocaine were very likely 
to have used legal substances as well as 
other illegal substances.
NORTHERN IRELAND  
– Key Findings
■ Over one-fifth of the adult population in 
Northern Ireland had not used any drugs 
(legal or illegal) in the last month.
■ The most commonly reported form of 
polydrug use involved alcohol and tobacco.
■ Just 6.36% of the respondents had used 
tobacco only in the previous month.
■ Polydrug use involving illegal substances 
is small at 2.11%.
■ A higher percentage of women 
(25%) than men (19%) reported not 
consuming any drug (legal or illegal) 
during the last month.
■ The combination of alcohol, tobacco 
and any illegal drug was much more 
common among males (3.70%) than 
females (0.55%).
■ More young adults aged 15-34 
combined alcohol, tobacco and any 
illegal drug (4.10%) than older adults 
aged 35-64 which was 0.55%.
■ For the combination of alcohol and 
tobacco there was an age-group 
difference; more young adults have  
tried this combination than is the  
case for older adults.
■ Respondents who reported having used 
cannabis were more likely to have reported 
using alcohol (92%) and tobacco (82%).
IRELAND AND NORTHERN 
IRELAND COMPARISON  
– Key Findings
■ Slightly more people in Northern Ireland 
(22%) than in Ireland (19%) did not 
take any drug (legal or illegal) in the  
last month.
■ The most common form of polydrug 
use was alcohol and tobacco for both 
Northern Ireland (23%) and Ireland 
(24%).
■ Whilst more people smoked tobacco 
only in Northern Ireland (6.36%) than 
in Ireland (5.27%), more people took 
alcohol only in Ireland (45%) than 
Northern Ireland (36%).
■ A greater number of men than women 
combined alcohol, tobacco and any 
illegal drug in Ireland than in Northern 
Ireland.
■ Combinations of illegal drug use was 
found in a small minority in both 
jurisdictions.
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Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Drug and 
Alcohol Information and Research Unit (DAIRU) within the 
Department of Health, Social Services and Public Safety 
(DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence rates for 
key illegal drugs such as cannabis, ecstasy, cocaine and heroin 
on a lifetime (ever used), last year (recent use) and last month 
(current use). Similar prevalence questions were also asked of 
alcohol, tobacco and other drugs such as tranquillisers. Attitudinal 
and demographic information was also sought from respondents.
Following an open tender process, the tender was awarded to 
MORI MRC to conduct the survey.
Methodology
The questionnaire and methodology for this survey were 
based on best practice guidelines drawn up by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The 
questionnaires were administered through face-to-face interviews 
with respondents aged between 15 and 64 years and who 
are normally resident in households in Ireland and Northern 
Ireland. Thus persons outside these age ranges, or who do not 
normally live in private households, have not been included in 
the survey. This approach is commonly used throughout the EU 
and because of the exclusion of those living in institutions (for 
example prisons, nursing homes etc.) this type of prevalence 
survey is usually known as a general population survey.
Fieldwork for the survey was carried out between October 2002 
and April 2003 and the final achieved sample comprised of 
8,434 respondents (4,918 in Ireland and 3,516 in Northern 
Ireland). The response rate for the survey was 70% in Ireland 
and 63% in Northern Ireland.
The sample was weighted by gender, age, Health Board1 in Ireland 
and Health and Social Services Board area in Northern Ireland, to 
maximise its representativeness of the general population.
Details of the methodology have been summarised in a paper 
published on the websites of the NACD (http://www.nacd.ie/) and 
the DHSSPS (http://www.dhsspsni.gov.uk/) and a comprehensive 
technical report containing copies of the questionnaires used in 
both jurisdictions is published on both websites.
1 Since January 2005 the Health Boards in Ireland have undergone restructuring and are merged under one authority – the Health Service Executive. The above 
reference relates to the Health Board structure detailed in Bulletin 2 - Drug Use in Ireland and Northern Ireland 2002/2003 Drug Prevalence Survey: Health 
Board (Ireland) & Health and Social Services Board (Northern Ireland) Results (Revised).
What is Prevalence?
The term prevalence refers to the proportion of a 
population who have used a drug over a particular 
time period. In general population surveys, 
prevalence is measured by asking respondents in  
a representative sample drawn from the population 
to recall their use of drugs. The three most widely 
used recall periods are: lifetime (ever used a drug), 
last year (used a drug in the last twelve months), 
and last month (used a drug in the last 30 days). 
Provided that a sample is representative of the  
total population, prevalence information obtained 
from a sample can be used to infer prevalence in 
the population.
Lifetime prevalence refers to the proportion of the 
sample that reported ever having used the named 
drug at the time they were surveyed. A person who 
records lifetime prevalence may or may not be 
currently using the drug. Lifetime prevalence should 
not be interpreted as meaning that people have 
necessarily used a drug over a long period of time 
or that they will use the drug in future.
Last year prevalence refers to the proportion of  
the sample that reported using a named drug in  
the year prior to the survey. For this reason, last  
year prevalence is often referred to as recent use.
Last month prevalence refers to the proportion  
of the sample that reported using a named drug  
in the 30-day period prior to the survey. Last month 
prevalence is often referred to as current use.  
A proportion of those reporting current use may  
be occasional (or first-time) users who happen to 
have used in the period leading up to the survey – 
it should therefore be appreciated that current use  
is not synonymous with regular use.
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Previous Publications
Initial results from the 2002/2003 Drug Prevalence Survey were 
published in Bulletin 1 (October 2003, revised June 2005), 
which gave lifetime, last year, and last month prevalence rates for 
key drugs for the island of Ireland, Ireland and Northern Ireland.
Bulletin 2, published in March 2004 (revised June 2005), 
contained comparable information for Ireland and its constituent 
Health Boards and Northern Ireland and its constituent Health 
and Social Services Board areas. Prevalence rates for alcohol 
and tobacco (and, relating to Northern Ireland only, for anabolic 
steroids and Nubain®) were also included in the tables.
Bulletin 3 (2002/2003) Drug Prevalence Survey: Cannabis 
Results) examined age of first use, regular use, type of cannabis 
used, method by which cannabis is used, how and where 
cannabis is obtained, reasons for stopping use, attitudes to 
cannabis use and perceptions of risk, together with the most 
common characteristics of typical cannabis users.
Bulletin 4 (2002/2003 Drug Prevalence Survey: Cocaine 
Results) contained prevalence rates for the use of cocaine and 
other information relating to cocaine use in Ireland and Northern 
Ireland including - age of first use; regular use, type of cocaine 
used (powder or crack), method by which cocaine is consumed, 
how and where cocaine is obtained, reasons for stopping use, 
perceptions of risk and a profile of users.
Understanding the Results  
of this Bulletin
This Bulletin (no. 5) is concerned with polydrug use, that is the 
use of more than one drug within the last month, in Ireland and 
Northern Ireland. Results are given for all respondents, aged 
between 15 and 64, by gender and by age (young adults aged 
15-34 and older adults aged 35-64) based on data provided  
for last month use.
All percentages presented in the text are rounded to the nearest 
whole number where possible. However, one or two decimal 
places are occasionally presented in the text to facilitate ease  
of comparison between small numbers.
Interpreting the Data
■ All figures are based on weighted data
■ All figures are rounded to the nearest decimal place
■ All figures are based on valid responses
■ Data is based on last month use.
■ For the purpose of this study: 
	 “legal drugs” refers to alcohol, tobacco, sedatives, 
tranquillisers and anti-depressants
	 “illegal drugs” refers to amphetamines, cannabis, cocaine 
powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents
	 “nothing” refers to respondents reporting that they had not 
used any drugs (legal or illegal) in the last month.
Definition of Polydrug use
There are a number of forms of polydrug use. The most general 
definition (and the form reported here) is concurrent drug use, 
which involves a person using at least two substances during the 
same time period (for example, having used both cocaine and 
ecstasy in the last month).
Polydrug use is associated with a number of negative 
consequences including mental and physical ill-health, violence, 
aggression and a range of social problems. Polydrug use is more 
likely to result in accidents and death (including death from 
overdose) than when a single substance is consumed.
There is evidence that polydrug use is common among people 
seeking drug treatment and that this pattern of usage may well  
be on the increase. A Health Research Board (HRB) report shows, 
that of all cases treated for problem drug use, the proportion of 
cases having problems with more than one drug increased from 
71% in 1998 to 76% in 2002 (HRB, 2005).2 The report also 
shows that the pattern of ‘additional’ drugs was linked to the main 
problem drug. For example, when an opiate was the main problem 
drug, the most common additional problem drugs were cannabis 
followed by benzodiazepines, other opiates and then cocaine.
In considering the results presented here, note that the figures 
for prevalence are for that specific combination of drugs ONLY. 
Thus, the figures for alcohol, refers to that group of people who 
consumed alcohol only, i.e., that group did not use any other 
substance, during that specified interval. A greater percentage 
than this will actually have consumed alcohol, but will also have 
used another substance (for example, smoked tobacco). The 
important point is that the tables presented in this report are not 
aimed at presenting information on the prevalence of individual 
substances but rather at the combination of drugs.
Future Publication
Bulletin 6 (the final publication from the survey) will present 
the results for use of sedatives, tranquillisers or anti-depressants 
(ST/ADs) use in Ireland and Northern Ireland. The report will 
contain prevalence data, age of first use, frequency of use, 
method of taking sedatives, tranquillisers or anti-depressants  
and how they were obtained.
2 Long, J., Lynn, E., Kelly, F. (2005) Trends in treated problem drug use in Ireland, 1998-2002. Occasional Paper No. 17. Dublin. Health Research Board
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Results – Ireland
Polydrug use – All adults  
Last month prevalence (Table 1)
Results from Table 1 show that nearly one-fifth (19%) of the 
adult population aged between 15 and 64 in Ireland had used 
no drugs (either legal or illegal) in the last month. In other words, 
a large proportion of adults are not current users of any substance.
While the largest proportion of respondents (45%) who 
consumed alcohol-only, the most frequent combination of 
polydrug use (24% of all adults) involved the two most familiar 
legal substances, i.e. alcohol and tobacco.
Looking at the overall figures, the percentage involving other forms of 
polydrug use, (apart from the combination of alcohol and tobacco) 
was low. The most frequently reported combination for alcohol, 
tobacco and any illegal drug was 1.93%. Again, it should be 
remembered that these drug use combinations do not indicate  
the level of consumption of any individual drug on its own.
Table 1: Ireland 
Drug use combinations – All adults (15-64)
Last month prevalence Frequency 
n = 98
Percent 
 Alcohol 2202 .78
2 Alcohol, Tobacco 8 2.0
3 Nothing 9 9.
 Tobacco 29 .27
 Alcohol, Tobacco, Any Illegal Drug 9 .93
6 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD) 67 .37
7 Alcohol, Tobacco, ST/AD  .0
8 ST/AD 2 0.8
9 Alcohol, Any Illegal Drug 30 0.6
0 Tobacco, ST/AD 2 0.9
 Tobacco, Any Illegal Drug 0 0.20
2 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 8 0.6
3 Tobacco, ST/AD, Any Illegal Drug 3 0.06
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
Gender (Tables 2 & 3)
A higher percentage of women (6.29%) than men (4.25%) had 
used tobacco-only, while a higher proportion of men (48%) than 
women (42%) had used alcohol-only.
The combination of alcohol, tobacco and any illegal drug is 
more common among males (2.65%) than females (1.20%). 
However, the gender differences for low-frequency combinations 
were small.
Table 2: Ireland 
Drug use combinations – Males
Last month prevalence Frequency 
n = 270
Percent 
 Alcohol 8 7.93
2 Alcohol, Tobacco 66 2.9
3 Nothing 39 .97
 Tobacco 0 .2
 Alcohol, Tobacco, Any Illegal Drug 6 2.6
6 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD) 26 .03
7 Alcohol, Any Illegal Drug 22 0.89
8 Alcohol, Tobacco, ST/AD 8 0.7
9 ST/AD 8 0.72
0 Tobacco, Any Illegal Drug 8 0.33
 Tobacco, ST/AD 7 0.27
2 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug  0.22
3 Tobacco, ST/AD, Any Illegal Drug  0.06
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
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Table 3: Ireland 
Drug use combinations – Females
Last month prevalence Frequency 
n = 28
Percent 
 Alcohol 08 .6
2 Alcohol, Tobacco 69 23.26
3 Nothing 7 22.3
 Tobacco  6.29
 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD) 2 .7
6 Alcohol, Tobacco, ST/AD 33 .3
7 Alcohol, Tobacco, Any Illegal Drug 29 .20
8 ST/AD 2 0.97
9 Tobacco, ST/AD 8 0.72
0 Alcohol, Any Illegal Drug 8 0.33
 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 3 0.0
2 Tobacco, Any Illegal Drug  0.06
3 Tobacco, ST/AD, Any Illegal Drug  0.06
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
Prevalence of polydrug use by age-group  
in the last month (Tables 4 & 5)
Looking at the figures for young versus older adults, a number  
of points of comparison emerge. Firstly, the percentage of 
respondents who had not used any substance is very similar 
(although, more young adults fall into this category). Secondly, 
the proportion of older adults who had used alcohol-only in 
the previous month (49%) was higher than the proportion of 
younger adults who reported using alcohol-only (41%).
Conversely, the percentage who had used alcohol and tobacco 
was greater among young adults (28%) than among older adults 
(21%).
There were no major differences in low-frequency combinations 
of substances apart from the combination of alcohol, tobacco 
and any illegal drug. Prevalence rates were higher (3.36%) for 
young adults than for older adults (0.64%).
Table 4: Ireland 
Drug use combinations – Young adults (15-34)
Last month prevalence Frequency 
n = 2333
Percent 
 Alcohol 90 0.7
2 Alcohol, Tobacco 67 27.73
3 Nothing 70 20.
 Tobacco 0 .6
 Alcohol, Tobacco, Any Illegal Drug 78 3.36
6 Alcohol, Any Illegal Drug 28 .8
7 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD) 7 0.72
8 Alcohol, Tobacco, ST/AD 6 0.70
9 Tobacco, Any Illegal Drug 7 0.29
0 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 6 0.2
 ST/AD  0.20
2 Tobacco, ST/AD  0.6
3 Tobacco, ST/AD, Any Illegal Drug 3 0.2
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
Table 5: Ireland 
Drug use combinations – Older adults (35-64)
Last month prevalence Frequency 
n = 28
Percent 
 Alcohol 23 8.6
2 Alcohol, Tobacco 38 20.83
3 Nothing 7 8.2
 Tobacco  6.00
 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD)  .96
6 ST/AD 37 .3
7 Alcohol, Tobacco, ST/AD 3 .3
8 Tobacco, ST/AD 2 0.80
9 Alcohol, Tobacco, Any Illegal Drug 6 0.6
0 Tobacco, Any Illegal Drug 3 0.
 Alcohol, Any Illegal Drug 2 0.09
2 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 2 0.09
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
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Relationship between use of particular substances with use of other substances – All adults (Table 6)
Patterns of polydrug use change when the data for specific drugs used was analysed. This table presents the pattern of association 
between the use of one substance and the use of another. For example, of the respondents who used alcohol (3,639), 37% also used 
tobacco and 3.1% also used cannabis.
In general, the commonly-used legal substances (alcohol and tobacco) are associated with less use of other substances than vice-versa. 
Thus, it can be seen that of those who had smoked tobacco, over four-fifths (81.9%) had drunk alcohol. However, for both of these 
substances, the number trying illegal and other substances was quite small. In contrast, users of cannabis, amphetamine-type stimulants, 
and cocaine were very likely to have used legal substances as well as other illegal substances. For example, of those who had used cannabis 
within the last month, over 90% had used alcohol and 84% had smoked tobacco. Of those who had used amphetamine-type stimulants, 
all had used alcohol, 87% had used tobacco, 59% cannabis, 19% cocaine and 7% had used sedatives, tranquillisers or anti-depressants.
Table 6: Ireland 
Use of one substance by users of another substance – All adults (15-64)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 4918 3639 1635 126 20 17 195
Alcohol 7.0 8.9 90. 00.0 9.6 6.8
Tobacco 33.3 36.8 83.9 87. 7.8 .
Cannabis 2.6 3. 6. 9.3 62.6 .7
ATS2 0. 0. . 9. 22. 0.7
Cocaine 0.3 0. 0.6 8. 9. 0.7
ST/AD3 .0 3. .3 7.3 7. 8.
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
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Use of one substance by users of another substance – Gender (Tables 7 & 8)
When comparing alcohol consumption amongst males and females, there was no consistent pattern. There was no difference in the 
percentage of respondents who had used tobacco. Gender differences were more evident when looking at the association of tobacco 
with other substances. Male users of tobacco were more likely to have drunk alcohol, used cannabis, amphetamine-type stimulants and 
cocaine. Female tobacco users were more likely to have used sedatives, tranquillisers or anti-depressants.
Gender differences among those who have used cannabis are more complex. Female users of cannabis were more likely to have drunk 
alcohol (93%), than males (87%). Male users of cannabis were more likely to have used amphetamine-type stimulants (11%) and 
cocaine (12.5%) than females (5.6% and 0.0%, respectively). On the other hand, female users of cannabis were more likely to have 
tried sedatives, tranquillisers or anti-depressants (9.7%) than male cannabis users (6.1%). Male users of amphetamine-type stimulants 
were more likely than females to have used other substances, the small number of respondents in this category should be borne in 
mind. Finally, male users of sedatives, tranquillisers or anti-depressants were likely to have also used cannabis (7%), amphetamine-type 
stimulants (1.9%) and cocaine (1.9%) while female users only reported cannabis use (3.3%).
Table 7: Ireland 
Use of one substance by users of another substance – Males
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 2470 1937 826 85 16 17 75
Alcohol 78. 8.3 88.6 00.0 9.6 6.
Tobacco 33. 36. 83.3 9.9 7.8 2.2
Cannabis 3. 3.9 8.6 8.0 62.6 7.0
ATS2 0.7 0.9 .8 .2 22. .9
Cocaine 0.7 0.8 .2 2. 23. .9
ST/AD3 3.0 2. 3.8 6. 8.6 8.
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Table 8: Ireland 
Use of one substance by users of another substance – Females
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 2448 1703 808 41 3 0 120
Alcohol 69.6 78. 93. 00.0 - 6.
Tobacco 33. 37.2 8.3 6.9 - .
Cannabis .7 2.2 .3 6.9 - 3.3
ATS2 0. 0.2 0.3 .6 - -
Cocaine - - - - - -
ST/AD3 .9 . 6.8 9.7 - -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
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Use of one substance by users of another substance – Age (Tables 9 & 10)
A comparison of Tables 9 and 10 shows that the pattern of alcohol use was different for young and older adults. Young adults who 
had drunk alcohol were more likely to have smoked tobacco (43%) and used cannabis (5.3%) but less likely to have used sedatives, 
tranquillisers or anti-depressants (2.2%). A fairly similar pattern is evident in the case of users of tobacco, i.e. young adults were more 
likely to have used alcohol and cannabis but less likely to have used sedatives, tranquillisers or anti-depressants. In the case of cannabis, 
there was a tendency for young adults more so than older adults, to have used other substances apart from sedatives, tranquillisers or 
anti-depressants.
A comparison between young and older adults with regard to amphetamine-type stimulants and cocaine was especially difficult given  
that there was only one respondent in the case of older adults.
With regard to sedatives, tranquillisers or anti-depressants users, young adults were more likely to have used other substances (legal and 
illegal) than older adults.
Table 9: Ireland 
Use of one substance by users of another substance – Young adults (15-34)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 2333 1741 864 101 19 16 50
Alcohol 7.6 86. 90.6 00.0 9. 77.
Tobacco 37. 2.9 82. 86.7 .2 6.6
Cannabis .3 .3 9.7 7.2 60.3 3.6
ATS2 0.8 . .9 0.7 7.7 2.9
Cocaine 0.7 0.8 .0 9. .9 2.9
ST/AD3 2. 2.2 3.3 6.7 7. 8.9
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Table 10: Ireland 
Use of one substance by users of another substance – Older adults (35-64)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 2585 1898 771 24 1 1 146
Alcohol 73. 76.8 87.8 00.0 00.0 60.
Tobacco 29.9 3.2 89.9 00.0 00.0 39.8
Cannabis 0.9 . 2.8 00.0 00.0 .6
ATS2 * 0. 0. . 00.0 -
Cocaine * 0. 0. . 00.0 -
ST/AD3 .6 .6 7. 9.8 - -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
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Results – Northern Ireland
Polydrug use – All adults  
Last month prevalence (Table 11)
Over one-fifth (22%) of the adult population in Northern Ireland 
had not used any drugs (legal or illegal) in the last month. While the 
largest proportion of respondents (36%) had consumed alcohol-
only, the most frequent combination of polydrug use involved 
alcohol and tobacco; this was the case for nearly one-quarter of 
respondents (23%). Just 6% of respondents had used tobacco-only.
The percentage of respondents reporting polydrug use, (excluding 
the combination of alcohol and tobacco) was low. The most 
frequently reported combination of polydrug use was alcohol, 
either in combination with tobacco and sedatives, tranquillisers 
or anti-depressants (2.90%), or combined with sedatives, 
tranquillisers or anti-depressants (2.50%) or the combination of 
alcohol, tobacco and any illegal drug (2.11%). Other combinations 
of drug use occur only infrequently in the findings from this survey.
Table 11: Northern Ireland 
Drug use combinations – All adults (15-64)
Last month prevalence Frequency 
n = 36
Percent 
 Alcohol 26 3.8
2 Alcohol, Tobacco 88 23.27
3 Nothing 767 2.83
 Tobacco 22 6.36
 Alcohol, Tobacco, Sedatives, 
Tranquillisers or Anti-depressants 
(ST/AD) 02 2.90
6 Alcohol, ST/AD 88 2.0
7 Alcohol, Tobacco, Any Illegal Drug 7 2.
8 ST/AD 73 2.07
9 Tobacco, ST/AD 66 .86
0 Alcohol, Any Illegal Drug 23 0.6
 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 9 0.2
2 Tobacco, Any Illegal Drug  0.3
3 Tobacco, ST/AD, Any Illegal Drug  0.
 ST/AD, Any Illegal Drug 2 0.0
 Any Illegal Drug  *
6 Alcohol, ST/AD, Any Illegal Drug  *
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this  
 drug combination
Gender (Tables 12 & 13)
A higher percentage of women than men reported not consuming 
any substance during the previous month. However, a larger 
proportion of women (7.6%) than men (5.1%) had used 
tobacco-only, while a larger proportion of men (40%) than 
women (32%) had used alcohol-only.
The combination of alcohol, tobacco and any illegal drug was 
more common among males (3.7%) than females (0.55%). 
However, the combinations of alcohol and sedatives, tranquillisers 
or anti-depressants, and alcohol, tobacco and sedatives, 
tranquillisers or anti-depressants were more frequently reported 
by women (3.11%, 4.03%, respectively) than men (1.87%, 
1.75%, respectively). Gender differences with regard to low-
frequency combinations were not substantial.
Table 12: Northern Ireland 
Drug use combinations – Males
Last month prevalence Frequency 
n = 739
Percent 
 Alcohol 692 39.79
2 Alcohol, Tobacco 2 2.8
3 Nothing 33 9.03
 Tobacco 89 .0
 Alcohol, Tobacco, Any Illegal Drug 6 3.70
6 Alcohol, Sedatives, Tranquillisers 
or Anti-depressants (ST/AD) 33 .87
7 Alcohol, Tobacco, ST/AD 30 .7
8 Tobacco, ST/AD 2 .39
9 ST/AD 2 .22
0 Alcohol, Any Illegal Drug 7 0.99
 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 7 0.
2 Tobacco, ST/AD, Any Illegal Drug  0.23
3 Tobacco, Any Illegal Drug 3 0.7
 ST/AD, Any Illegal Drug 2 0.
 Any Illegal Drug  0.07
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
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Table 13: Northern Ireland 
Drug use combinations – Females
Last month prevalence Frequency 
n = 777
Percent 
 Alcohol 69 32.00
2 Nothing 37 2.7
3 Alcohol, Tobacco 398 22.38
 Tobacco 3 7.60
 Alcohol, Tobacco, Sedatives, 
Tranquillisers or Anti-depressants 
(ST/AD) 72 .03
6 Alcohol, ST/AD  3.
7 ST/AD 2 2.90
8 Tobacco, ST/AD  2.32
9 Alcohol, Tobacco, Any Illegal Drug 0 0.
0 Alcohol, Any Illegal Drug  0.30
 Tobacco, Any Illegal Drug 2 0.09
2 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 2 0.08
3 Alcohol, ST/AD, Any Illegal Drug  0.0
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this  
 drug combination
Prevalence of polydrug use by age-group  
in the last month (Tables 14 & 15)
A comparison of young and older adults in Northern Ireland shows 
a number of similarities and differences. Firstly, the percentage 
who had tried no substance is very similar, the difference between 
young adults (22.16%) and older adults (21.56%) is less than 
one percentage point. Secondly, the number of young adults who 
had used alcohol-only (35%), is quite similar to the figure for 
older adults (37%). Thirdly, the figure for tobacco-only is quite 
similar for young (6%) and older adults (7%).
However, for the combination of alcohol and tobacco there was 
a difference; a larger proportion of young adults (26%) had tried 
this combination than older adults (21%). On the other hand, 
3.56% of older adults reported having used alcohol, tobacco 
and sedatives, tranquillisers or anti-depressants compared with 
2.07% for young adults. For users of alcohol and sedatives, 
tranquillisers or anti-depressants only, the percentage of older 
adults was 3.36% while for young adults the percentage was 
1.41%. Prevalence rates were higher in the reported use of 
sedatives, tranquillisers or anti-depressants only for older adults 
(3.09%) compared with young adults (0.77%).
Table 14: Northern Ireland 
Drug use combinations – Young adults (15-34)
Last month prevalence Frequency 
n = 0
Percent 
 Alcohol 2 3.97
2 Alcohol, Tobacco, 03 26.00
3 Nothing 33 22.6
 Tobacco 90 .79
 Alcohol, Tobacco, Any Illegal Drug 6 .0
6 Alcohol, Tobacco, Sedatives, Tranquillisers  
or Anti-depressants (ST/AD) 32 2.07
7 Alcohol, ST/AD 22 .
8 Alcohol, Any Illegal Drug 2 .38
9 ST/AD 2 0.77
0 Tobacco, ST/AD  0.69
 Tobacco, ST/AD, Any Illegal Drug  0.2
2 Tobacco, Any Illegal Drug  0.23
3 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 3 0.6
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this  
 drug combination
Table 15: Northern Ireland 
Drug use combinations – Older adults (35-64)
Last month prevalence Frequency 
n = 966
Percent 
 Alcohol 79 36.
2 Nothing 2 2.6
3 Alcohol, Tobacco  2.2
 Tobacco 3 6.8
 Alcohol, Tobacco, Sedatives, Tranquillisers  
or Anti-depressants (ST/AD) 70 3.6
6 Alcohol, ST/AD 66 3.36
7 ST/AD 6 3.09
8 Tobacco, ST/AD  2.79
9 Alcohol, Tobacco, Any Illegal Drug  0.
0 Alcohol, Tobacco, ST/AD,  
Any Illegal Drug 6 0.3
 ST/AD, Any Illegal Drug 2 0.09
2 Alcohol, Any Illegal Drug  0.06
3 Tobacco, Any Illegal Drug  0.0
 Alcohol, ST/AD, Any Illegal Drug  0.0
All figures are based on weighted data, valid responses, and are rounded to the nearest 
decimal place or two decimal places where appropriate. 
1 For the purpose of this study, “illegal drugs” refers to amphetamines, cannabis, cocaine  
 powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this  
 drug combination
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Relationship between use of particular substances with use of other substances – All adults (Table 16)
Patterns of polydrug use change when the data for specific drugs used was analysed. This table presents the pattern of association  
between the use of one substance and the use of another. For example, of the respondents who used alcohol (2,375), 44% also  
used tobacco and 4% also used cannabis.
Overall, it was evident that the use of alcohol and tobacco was associated to a lesser extent with the use of other substances than  
vice-versa. Thus, it can be seen that of those who had smoked tobacco, nearly four-fifths (77%) had drunk alcohol. However, for  
both of these substances, the number trying illegal and other substances was quite small.
The respondents who reported having used cannabis were more likely to have reported using alcohol (92%) and tobacco (82%).  
A minority of cannabis users were also likely to report the use of amphetamine-type stimulants (18%) and sedatives, tranquillisers  
or anti-depressants (12%).
In the case of current amphetamine-type stimulant users, while the majority used alcohol (88%) and tobacco (64%), none had used 
cocaine and nearly one-quarter had used sedatives, tranquillisers or anti-depressants (24%). The very small number of current cocaine 
users (3 users) makes any cross-comparisons very difficult. Over half of current users of sedatives, tranquillisers or anti-depressants had 
also used alcohol (58%) and tobacco (53%). Only a small percentage of users of sedatives, tranquillisers or anti-depressants had used 
cannabis (3.5%) or amphetamine-type stimulants (1.7%)
Table 16: Northern Ireland 
Use of one substance by users of another substance – All adults (15-64)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 3516 2375 1301 103 24 3 343
Alcohol 67.6 77. 9. 87.9 00.0 8.
Tobacco 37.0 .2 8.7 6. 6.6 2.
Cannabis 2.9 .0 6. 77.9 6.6 3.
ATS2 0.7 0.9 .2 7.9 - .7
Cocaine 0. 0. 0. .8 - -
ST/AD3 9.8 8. 3.8 .6 2.2 -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Use of one substance by users of another substance – Gender (Tables 17 &18)
When comparing alcohol use among males and females, the picture is quite similar, except with use of sedatives, tranquillisers or anti-
depressants. Double the proportion of females (12%) who used alcohol have used sedatives, tranquillisers or anti-depressants, compared 
to males (5.5%). There are some gender differences with respondents who have used tobacco; a higher percentage of males than 
females who have used tobacco have also used alcohol (81%, 73%, respectively), while a higher percentage of females who used 
tobacco have also used sedatives, tranquillisers or anti-depressants (17%) when compared to males (10%).
A larger proportion of male cannabis users had also used other substances in comparison with female users, except in the case of 
sedatives, tranquillisers or anti-depressants where the percentage is similar. However, the relatively small number of female cannabis users 
should be taken into account. There are also difficulties in making gender comparisons with regard to amphetamine-type stimulants and 
cocaine, because of the small number of reported female amphetamine-type stimulant users (3) and cocaine users (zero).
With regard to users of sedatives, tranquillisers or anti-depressants, the association with alcohol and tobacco use results are similar. However, 
a larger proportion of males than females who have used sedatives, tranquillisers or anti-depressants have also used cannabis (9%, 
0.7%, respectively) and amphetamine-type stimulants (4.7%, 0.0%, respectively).
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Table 17: Northern Ireland 
Use of one substance by users of another substance – Males
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 1739 1264 642 89 21 3 121
Alcohol 72.7 8.3 92.0 86. 00.0 7.8
Tobacco 37.0 .3 8. 66. 6.6 .2
Cannabis . 6. .7 8.0 6.6 8.
ATS2 .2 . 2.2 9. - .7
Cocaine 0.2 0.2 0.3 2. - -
ST/AD3 7.0 . 0.2 .6 27.2 -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Table 18: Northern Ireland 
Use of one substance by users of another substance – Females
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 1777 1111 659 14 3 0 222
Alcohol 62. 73.0 88.7 00.0 - 8.2
Tobacco 37. 3.3 63.9 7.6 - .
Cannabis 0.8 . . 2. - 0.7
ATS2 0. 0.2 0.2 9.9 - -
Cocaine - - - - - -
ST/AD3 2. .6 7. .9 - -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Use of one substance by user of another substance – Age (Tables 19 & 20)
Differences between young and older adults (Tables 19 & 20) in the use of many of the substances were observed. In the case of 
alcohol, there was a greater tendency for young adults to have used tobacco (46%) and cannabis (7%) than older adults (39% and 
1.4% respectively). However, older alcohol users were more likely to have used sedatives, tranquillisers or anti-depressants (11%) than 
younger adults (5.2%).
The same pattern of difference was evident with regard to tobacco use. A larger proportion of young tobacco users (82%) had also used 
alcohol than older tobacco users (73%). Similarly, young tobacco users were more likely to have used cannabis (11%) than older users 
(2.3%). However, older tobacco users were more likely to report using sedatives, tranquillisers or anti-depressants (19%) than younger 
adults (8.1%).
There were no major differences between young and older adults with regard to cannabis users and the use of alcohol (91%, 94%, 
respectively) and tobacco (81%, 84%, respectively). The majority of all cannabis users had used alcohol and tobacco. However, there were 
differences with regard to other substances. A larger proportion of young adults (21%) who had used cannabis had also used amphetamine-
type stimulants than older adults (5.7%). There were also differences with regard to sedatives, tranquillisers or anti-depressants; 6.8 % of 
young adults who had used cannabis had also used sedatives, tranquillisers or anti-depressants compared with 33% of older adults.
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Obviously, there is a need for caution in comparing young and older users of amphetamine-type stimulants given the small number 
of amphetamine-type stimulants users (4). The trend was for higher prevalence rates of other substances by young adults except with 
respect to sedatives, tranquillisers or anti-depressants. A comparison in the case of cocaine was not possible.
Finally, with respect to users of sedatives, tranquillisers or anti-depressants, a larger proportion young adults reported having used other 
substances than older adults. While 68% of young users of sedatives, tranquillisers or anti-depressants had also used alcohol, the 
corresponding percentage for older adults was 55%. Similarly with tobacco, the relevant percentages were 60% (young adults) and 50% 
(older adults). The same pattern was evident for cannabis and amphetamine-type stimulants.
Table 19: Northern Ireland 
Use of one substance by users of another substance – Young adults (15-34)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 1550 1068 609 94 20 3 83
Alcohol 70. 82.3 9.0 9.9 00.0 68.0
Tobacco 39.3 6. 8.2 67.0 6.6 9.
Cannabis . 7.0 .2 86.6 6.6 6.9
ATS2 .3 .7 2.2 20.6 - 2.
Cocaine 0.2 0.3 0.3 2.3 - -
ST/AD3 . .2 8. 6.8 0.3 -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
Table 20: Northern Ireland 
Use of one substance by users of another substance – Older adults (35-64)
Last Month 
Prevalence
Users of 
Alcohol
Users of 
Tobacco
Users of 
Cannabis
Users of 
ATS2
Users of 
Cocaine
Users of 
ST/AD3
N (weighted) 1966 1298 692 19 4 0 260
Alcohol 6. 72.6 9.0 0. - .9
Tobacco 3.2 39.0 83.6 0. - 0.2
Cannabis .0 . 2.3 30. - 2.
ATS2 0.2 0. 0.3 .7 - .
Cocaine - - - - - -
ST/AD3 3.2 . 8.9 32. 00.0 -
All figures are based on weighted data, valid responses, and are rounded to the nearest decimal place or two decimal places where appropriate. 
2 Amphetamine-type stimulants (Ecstasy and Amphetamines) 
3 Sedatives, Tranquillisers or Anti-depressants 
- No person surveyed reported the use of this drug combination 
* Less than half of 0.1 per cent (<0.05%) of those surveyed reported the use of this drug combination
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Comparison – Ireland and 
Northern Ireland
A number of important similarities in polydrug use emerged from 
Northern Ireland and Ireland. The first was the large percentage 
(around one-fifth) in both jurisdictions of respondents who had 
used no substance (either legal or illegal) in the last month. It is 
also important to note that this pattern of non-use is not confined 
to any single age-group or gender; among young and older adults 
and among males and females, a minority fall into this category.
Another finding was that the most common polydrug 
combination was alcohol and tobacco, 24% of respondents in 
Ireland and 23% of respondents in Northern Ireland reported 
this combination of polydrug use. Again this pattern of use was 
consistent across gender and age-groups in both jurisdictions.
In both Northern Ireland and Ireland, the largest proportion 
of respondents was those who used alcohol-only during the 
previous month, 45% of the respondents in Ireland compared  
to 36% in Northern Ireland. The difference was most pronounced 
in the case of older adults; 37% of older adults in Northern 
Ireland were current users, while in Ireland the results were 
much higher at 49%.
The combination of polydrug use for alcohol, tobacco and any 
illegal drug is found in a small minority, in Ireland (1.93%) and 
Northern Ireland (2.11%). The proportion of polydrug use of 
illegal drugs in lower is both jurisdictions.
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